levofloxacin has been researched along with ipratropium bromide anhydrous in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (ipratropium bromide anhydrous) | Trials (ipratropium bromide anhydrous) | Recent Studies (post-2010) (ipratropium bromide anhydrous) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 17 | 1 | 7 |
| Protein | Taxonomy | levofloxacin (IC50) | ipratropium bromide anhydrous (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0021 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0028 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
1 other study(ies) available for levofloxacin and ipratropium bromide anhydrous
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |